Digipath
Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

PMCB RSS Feed
Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: mick, efood125, Hunchbackgeek, $Pistol Pete$, thenewmixer, fraum
Search This Board: 
Last Post: 12/18/2018 8:19:45 AM - Followers: 794 - Board type: Free - Posts Today: 5

Welcome to PharmaCyte BioTech
An OTCQB Company

http://pharmacyte.com/  




 




 
 
 
 




PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.
 

 

FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment



European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000395.jsp&mid=WC0b01ac058001d12b

 Company Address
   
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com
http://pharmacyte.com/
 

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
848,904,665 a/o Aug 29, 2016

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

Float:
817,204,665 a/o Aug 29, 2016


For more updated information please visit: 


http://www.otcmarkets.com/stock/PMCB/profile


Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations


Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States

 

   All News Releases: 

http://www.pharmacytebiotech.com/news/

 


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans.


http://austrianova.com/products/ 



Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President
 

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director


Carlos A. Trujillo – Chief Financial Officer and Director


Walter H. Gunzburg – Chief Scientific Officer


Dr. Matthias Lohr as Chairman of Scientific Advisory Board


Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board

 


 

 

 


***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.





 
 


                                   

 
 
Digipath
PMCB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Quarterly Report (10-q) 12/14/2018 05:37:56 PM
PMCB News: Quarterly Report (10-q) 09/12/2018 05:26:18 PM
PMCB News: Annual Report (10-k) 07/20/2018 05:20:41 PM
PlusOneCoin Top Posts
#88950   PR from 2004...sound familar? Hotelier51 12/14/18 08:46:30 AM
#89031   A recap of all the stock crooks associated Hotelier51 12/16/18 03:13:54 PM
PostSubject
#88890  Sticky Note $PMCB What makes Cell-in-a-Box different fro $Pistol Pete$ 12/11/18 01:41:35 PM
#88884  Sticky Note $PMCB PharmaCyte Discusses Pancreatic Cancer Clinical Tr $Pistol Pete$ 12/11/18 12:46:07 PM
#80476  Sticky Note PMCBs CC https://fccdl.in/1r0d8hpkC. thenewmixer 01/30/18 01:43:58 PM
#79557  Sticky Note HUGE READ MY FRIEND/ PHARMACYTE BIOTECH/ $PMCB/ STAY mick 01/10/18 10:06:32 AM
#89106   Good morning PMCB MONEYBAGSCLAY 12/18/18 08:19:45 AM
#89105   Best to have more patience. PINKribbon 12/18/18 08:01:48 AM
#89104   An IND filing coupled with a funding PR BioInvestor4 12/18/18 08:01:13 AM
#89103   Are you living in la la land Pink. A2Z 12/18/18 07:40:13 AM
#89101   I agree efood...I think that’s exactly what’s going PINKribbon 12/17/18 10:03:53 PM
#89100   Lol...what if waggs is raising this capital to efood125 12/17/18 07:55:39 PM
#89099   We plan to continue selling securities under the concordia 12/17/18 07:46:44 PM
#89097   I have to admit I invested my retirement thenewmixer 12/17/18 05:34:02 PM
#89096   They have gone along way from nowhere Brian903 12/17/18 05:06:20 PM
#89095   Thx for reminding me of this cc Brian903 12/17/18 05:05:28 PM
#89094   if anyone needs info on Ciab pm me.....I thenewmixer 12/17/18 04:48:26 PM
#89093   yes we are all old make believe rocket scientists thenewmixer 12/17/18 04:45:41 PM
#89092   BACK UP THE TRUCK AND LOAD UP ON concordia 12/17/18 04:39:29 PM
#89089   your "group". LOL rcstock 12/17/18 03:56:00 PM
#89088   It would be nice if your group was hockeypond 12/17/18 03:45:10 PM
#89087   my group is buy up all the shares thenewmixer 12/17/18 03:17:17 PM
#89086  Restored BACK UP THE TRUCK AND LOAD UP ON concordia 12/17/18 01:54:05 PM
#89085   Getting closer to .05 MONEYBAGSCLAY 12/17/18 01:26:49 PM
#89084   glad I was able to pick up those thenewmixer 12/17/18 01:24:37 PM
#89083   What information that based on? A_realist 12/17/18 01:13:33 PM
#89082   Yep we are closer to ind-in 10yrs? bearspread 12/17/18 01:10:36 PM
#89081   Yesterday was the 2-year anniversary of the announcement bearspread 12/17/18 12:59:47 PM
#89080   We are not selling these golden scam shares bearspread 12/17/18 12:46:03 PM
#89079   Yesterday was the 2-year anniversary of the announcement takeyouhigher 12/17/18 12:19:59 PM
#89078   PMCB PPS TARGETS-definition of "Short term" bearspread 12/17/18 12:15:20 PM
#89077   We are not selling these golden shares until longboarder7892 12/17/18 11:33:57 AM
#89075   Yep we are closer to ind I think MONEYBAGSCLAY 12/17/18 11:22:20 AM
#89074   Early next year will be fun for us here $Pistol Pete$ 12/17/18 11:20:18 AM
#89073   PMCB WILL BREAK 52 wk high soon imo MONEYBAGSCLAY 12/17/18 11:19:27 AM
#89071   I agree looking at L2 VERT is sitting MONEYBAGSCLAY 12/17/18 11:16:27 AM
#89070   Chart is crying for the bounce back $Pistol Pete$ 12/17/18 11:15:33 AM
#89069   Yes sir looks like it to me L2 thin MONEYBAGSCLAY 12/17/18 11:15:28 AM
#89068   Sellers is almost done and ready for the reversal $Pistol Pete$ 12/17/18 11:15:01 AM
#89067   NICE VOLUME ALREADY MAYBE WE GET A NICE MONEYBAGSCLAY 12/17/18 11:14:38 AM
#89066   GM and I think so too $Pistol Pete$ 12/17/18 11:14:01 AM
#89065   PMCB COULD BE BACK OVER .05 SOON SMART MONEYBAGSCLAY 12/17/18 11:13:05 AM
#89064   PMCB PPS TARGETS .10/.15 SHORT TERM MONEYBAGSCLAY 12/17/18 11:05:30 AM
#89063   PMCB GREEN THIS MORNING MONEYBAGSCLAY 12/17/18 11:04:39 AM
#89062   GM MICK $Pistol Pete$ 12/17/18 11:04:10 AM
#89061   Every "block sale" of shares are resold at concordia 12/17/18 11:02:52 AM
#89060   Well the good news is those shares were longboarder7892 12/17/18 10:57:03 AM
#89059   G'mornin Efood , all it esusun 12/17/18 10:28:48 AM
#89058   Thank you Wolfy . Best to you esusun 12/17/18 10:24:55 AM
#89057   Who is buying shares at .0425 when PMCB concordia 12/17/18 10:21:26 AM
#89056   careful, let’s not get kw panties in a bearspread 12/17/18 10:20:52 AM
#89055   That’s a huge plus PMCB MONEYBAGSCLAY 12/17/18 10:12:28 AM
#89054   Good morning mick pmcb good entry pps MONEYBAGSCLAY 12/17/18 10:10:27 AM
#89053   If waggs...crabtree... gunzburg...salmons... bearspread 12/17/18 10:04:39 AM
#89052   careful, let’s not get kw panties in a tulla236a 12/17/18 09:48:59 AM
#89051   tulla236a 12/17/18 09:48:52 AM
PostSubject